Unravelling Signalling Heterogeneity using DEEP Learning and MECHANIstic Modelling
This project aims to develop innovative computational methods combining deep learning and mechanistic modeling to predict cell signaling responses and address heterogeneity in cancer treatment.
Projectdetails
Introduction
Signalling enables cells to respond to external cues, but the inherent heterogeneity of individual cell responses, essential for multicellular organization, complicates disease treatment. Heterogeneity arises from drivers at system and molecular scales, intertwined through feedback loops, making quantitative understanding and prediction challenging.
Objective
I will address this by pioneering transformative computational methods that predict phospho-signalling responses by integrating deep learning with mechanistic modelling to integrate systems and molecular scales.
Methodology
By using unbiased pattern recognition of deep learning models, I will learn cell states and simple phosphorylation rate laws. These will be combined with mechanistic models, integrating biological knowledge, to build simple and interpretable models that predict signalling responses from baseline omics profiles across distinct time-resolved and perturbational conditions.
Application
I will apply these methods to investigate drivers of heterogeneity in receptor tyrosine kinase (RTK) and rat sarcoma (RAS) signalling, in response to growth factors and targeted inhibitors in cancer cell lines. I will validate the approach by reprogramming patient-derived organoids using model-proposed inhibitor combinations.
Impact
The proposed research will advance our fundamental understanding of signalling regulation and co-regulation with cellular states. Given the vital role of RTK and RAS signalling in human health, it also holds the potential for translational impact.
Broader Implications
More broadly, the proposed computational methods are versatile and could be applied to a broad range of biological and non-biological systems.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.499.466 |
Totale projectbegroting | € 1.499.466 |
Tijdlijn
Startdatum | 1-10-2024 |
Einddatum | 30-9-2029 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- THE FRANCIS CRICK INSTITUTE LIMITEDpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Integrated Mechanistic Modelling and Analysis of Large-scale Biomedical DataINTEGRATE aims to enhance cancer treatment by developing advanced computational models that integrate patient-derived data for improved drug targeting and clinical trial planning. | ERC Consolid... | € 1.854.546 | 2024 | Details |
Learning and modeling the molecular response of single cells to drug perturbationsDeepCell aims to model cellular responses to drug perturbations using multiomics and deep learning, facilitating optimal treatment design and expediting drug discovery in clinical settings. | ERC Advanced... | € 2.497.298 | 2023 | Details |
Physical basis of Collective Mechano-Transduction: Bridging cell decision-making to multicellular self-organisationThis project investigates how mechanical forces in tissue microenvironments influence gene expression and multicellular behavior, aiming to bridge biophysics and biochemistry for improved disease therapies. | ERC Starting... | € 1.499.381 | 2022 | Details |
Personalised Mechanobiological Models to Predict Tumour Growth and Anti-Cancer Drug PenetrationThis project aims to develop a personalized cancer treatment framework by modeling stress-dependent tumor growth and drug penetration to enhance patient-specific therapy outcomes. | ERC Starting... | € 1.499.693 | 2024 | Details |
Understanding the functional role of Immune-related Intercellular Signalling Networks during tissue Development and CancerThis project aims to uncover immune-related intercellular crosstalk in tissue development and cancer using single-cell RNA-sequencing and functional assays to identify novel therapeutic targets. | ERC Starting... | € 2.025.000 | 2022 | Details |
Integrated Mechanistic Modelling and Analysis of Large-scale Biomedical Data
INTEGRATE aims to enhance cancer treatment by developing advanced computational models that integrate patient-derived data for improved drug targeting and clinical trial planning.
Learning and modeling the molecular response of single cells to drug perturbations
DeepCell aims to model cellular responses to drug perturbations using multiomics and deep learning, facilitating optimal treatment design and expediting drug discovery in clinical settings.
Physical basis of Collective Mechano-Transduction: Bridging cell decision-making to multicellular self-organisation
This project investigates how mechanical forces in tissue microenvironments influence gene expression and multicellular behavior, aiming to bridge biophysics and biochemistry for improved disease therapies.
Personalised Mechanobiological Models to Predict Tumour Growth and Anti-Cancer Drug Penetration
This project aims to develop a personalized cancer treatment framework by modeling stress-dependent tumor growth and drug penetration to enhance patient-specific therapy outcomes.
Understanding the functional role of Immune-related Intercellular Signalling Networks during tissue Development and Cancer
This project aims to uncover immune-related intercellular crosstalk in tissue development and cancer using single-cell RNA-sequencing and functional assays to identify novel therapeutic targets.